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ABSTRACT
The catabolite control protein CcpA is a pleiotropic
regulator that mediates the global transcriptional
response to rapidly catabolizable carbohydrates,
like glucose in Gram-positive bacteria. By whole
transcriptome analyses, we characterized glucose-
dependent and CcpA-dependent gene regulation in
Clostridium difficile. About 18% of all C. difficile
genes are regulated by glucose, for which 50%
depend on CcpA for regulation. The CcpA regulon
comprises genes involved in sugar uptake, fermen-
tation and amino acids metabolism, confirming the
role of CcpA as a link between carbon and nitrogen
pathways. Using combination of chromatin immu-
noprecipitation and genome sequence analysis, we
detected 55 CcpA binding sites corresponding to
!140 genes directly controlled by CcpA. We
defined the C. difficile CcpA consensus binding
site (creCD motif), that is, ‘RRGAAAANGTTTTCWW’.
Binding of purified CcpA protein to 19 target creCD
sites was demonstrated by electrophoretic mobility
shift assay. CcpA also directly represses key factors
in early steps of sporulation (Spo0A and SigF).
Furthermore, the C. difficile toxin genes (tcdA and
tcdB) and their regulators (tcdR and tcdC) are direct
CcpA targets. Finally, CcpA controls a complex and
extended regulatory network through the modula-
tion of a large set of regulators.
INTRODUCTION
Clostridium difficile, a Gram-positive, anaerobic, spore
forming bacterium, is an emerging pathogen. It is the
leading cause of antibiotic-associated diarrhoea and is
implicated in almost all cases of pseudomembranous
colitis in humans. A higher morbidity and mortality rate
because of C. difficile has been described in recent years
(1,2). The development of C. difficile infection (CDI) is
usually associated with antibiotic treatment, which
disrupts the gut flora, allowing this bacterium to
colonize the intestine (3). The spectrum of diseases
caused by C. difficile is highly variable and depends not
only on host factors but also, for the severe forms, on the
level of toxin production (4).
The pathology process of C. difficile is divided in three
main steps as follows: spore germination, host coloniza-
tion and toxin production. After host infection by
C. difficile spores, germination occurs, and the vegetative
forms multiply in the gut. Clostridium difficile can adhere
to the mucus layer and colonize the human gut (5).
Pathogenic strains then produce two toxins (TcdA and
TcdB), which are considered as the major virulence
factors, that lead to the disruption of the actin cytoskel-
eton of intestinal epithelium cells (6,7), therefore,
conferring the CDI symptoms (diarrhoea, epithelial
apoptosis and ulceration). The toxin genes lie within a
19.6-kb pathogenicity locus (PaLoc) that also includes
three accessory genes encoding the specific transcriptional
regulators of toxin genes (TcdR and TcdC), and a
holin-like pore forming protein (TcdE) involved in toxin
secretion (8–10).
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Among the other potential virulence factors,
Clostridium difficile binary toxin (CDT), which is produced
by 35% of C. difficile strains, has been recently shown to
play a role in adherence to the host intestinal epithelial
cells (11). Other factors, such as the adhesin Cwp66, the
flagellum, the fibronectin-binding protein FbpA and the
surface layer protein SlpA also play a role in cell adher-
ence [for review see reference (5)]. Clostridium difficile also
displays some surface proteolytic activities that seem to
contribute to nutrients release (12), such as the cysteine
protease Cwp84, which is also involved in SlpA matur-
ation (13). Nevertheless, in vivo virulence processes of
CDI are still poorly understood.
Many bacterial pathogens produce virulence factors to
overcome the drastic changes in environment that they
encounter during infection. Consequently, the regulation
of the virulence genes is an important step of the patho-
genicity process. In C. difficile, toxin production increases
as cells enter into stationary phase and is modulated in
response to different environmental signals, such as tem-
perature, biotin limitation, the presence of antibiotics, of
butyric acid or butanol and of certain amino acids like
cysteine or proline (14). This indicates a correlation
between environmental signals and virulence factors regu-
lation. The transcription of tcdA and tcdB is also repressed
by the presence of rapidly metabolizable carbohydrates,
such as glucose or other sugars taken up by the
phosphoenolpyruvate-dependent phosphotransferase
system (PTS) (15). The PTS is composed of enzyme I
and histidine-containing phosphocarrier protein (HPr),
present in the cytoplasm, and the carbohydrate specific
transporter enzyme II, consisting usually of three
domains (EIIA, EIIB and EIIC). The carbon catabolite
repression (CCR) in bacteria is generally regarded as a
regulatory mechanism to ensure sequential utilization of
carbohydrates (16). CCR has been extensively studied in
Bacillus subtilis [for review see references (16,17)]. The
global mechanism of CCR is mediated by the pleiotropic
regulator CcpA, a member of the LacI/GalR family of
transcription factors (16). CcpA represses the transcrip-
tion of several hundred catabolic genes and activates the
expression of some genes of overflow metabolism (17).
Positive and negative transcriptional regulation of
CcpA-controlled genes involves the binding of CcpA to
the cis-acting catabolite responsive element named cre
site. In Bacilli, the DNA-binding activity of CcpA is
enhanced by its interaction with HPr-Ser-P, a
phosphorylated form of HPr (16). Although CcpA
controls most genes subjected to catabolite control in
B. subtilis, transcriptomic data have also revealed the
existence of CcpA-independent CCR mechanisms (18,19).
CcpA plays a central role in the control of metabol-
ism in several Firmicutes, such as Lactococcus lactis,
Bacillus cereus, Clostridium acetobutylicum and sev-
eral streptococci and staphylococci (20–24). CcpA also
regulates the expression of virulence-associated genes.
In Staphylococcus aureus, Streptococcus pneumoniae,
Clostridium perfringens and Bacillus anthracis, CcpA par-
ticipates in the control of toxin production, colonization,
capsule synthesis, biofilm formation and/or antibiotic re-
sistance (25–29). Moreover, ccpAmutants of S. aureus and
B. anthracis are attenuated on virulence in animal models
of infection (24,28). The coordinate CcpA-dependent
regulation of virulence and carbon utilization genes
might be critical for fitness when pathogens compete
with other microbes for niche colonization (23).
Recently, we have demonstrated that CcpA is involved
in the glucose-dependent repression of C. difficile toxin
production. This repression is because of a direct
binding of CcpA to the regulatory region of the tcdA
and tcdB genes (30). This is the first evidence that CcpA
acts as a link between carbon source utilization and viru-
lence gene expression in C. difficile. This bacterium has a
large repertoire of genes dedicated to carbohydrate catab-
olism. Clostridium difficile ability to use an extended range
of carbohydrates might be important during the patho-
genesis process by promoting survival and growth in the
intestine (31). Moreover, other factors important for in-
fection and pathogenesis (besides the two major toxins)
may be under CCR. The aim of this study was to
analyse the global impact of glucose on gene expression
and the regulatory role of CcpA in C. difficile. To define
the processes coordinately controlled by glucose mediated
or not by CcpA, we performed a transcriptome analysis of
JIR8094 and its isogenic ccpA mutant strains grown in the
presence or absence of glucose. We further combined a
genome scale in vivo determination of CcpA direct
targets to an in silico analysis and an in vitro protein-
DNA interaction study to define the CcpA DNA-
binding motif, therefore, characterizing the CcpA
regulon in C. difficile. The transcriptomic data were also
correlated with phenotypic tests concerning the impact of
glucose addition and CcpA inactivation on the fermenta-
tion process and sporulation efficiency. The data obtained
in this study provide new insights into understanding the
links between nutrient acquisition and virulence in
C. difficile.
MATERIALS AND METHODS
Bacterial strains and growth conditions
The C. difficile strain JIR8094 (32) and its isogenic !ccpA
mutant (30) were grown anaerobically (5% H2, 5% CO2
and 90% N2) in tryptone–yeast extract (TY) or TY
medium containing 0.5% glucose (TYG) in Freter
chamber (15). Sporulation medium (SM) (33) was used
for sporulation assays. SM medium contained per liter:
90 g Bacto–tryptone, 5 g Bacto–peptone, 1 g (NH4)2SO4,
1.5 g Tris base and pH at 7.4. When necessary, cefoxitin
(25 mg/ml) or erythromycin (2.5 mg/ml) was added to
C. difficile cultures.
Sporulation assay
Mid-exponential growth cultures of C. difficile JIR8094
and its isogenic ccpA mutant in SM medium were used
to inoculate 5ml of SM broth or SM broth supplemented
with 0.5% glucose. After 24, 48 and 96 h of growth, 350 ml
of culture was divided into two samples. To determine the
number of colony forming unit (CFU), one sample was
serially diluted and plated on Brain–Heart Infusion (BHI)
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with 0.1% taurocholate (Sigma). To determine the
number of spores in the culture, the other sample was
heated at 60"C for 30min before plating in BHI with
0.1% taurocholate. The percentage of sporulation was
determined as the ratio of the number of spores/ml and
the number of bacteria per millilitre.
Volatile fatty acid analysis
The end products of bacteria fermentation were detected
by gas–liquid chromatography. Strain JIR8094 and the
ccpA mutant were grown in TY or TYG for 48 h at
37"C. After centrifugation, supernatants were recovered
and mixed with sulphuric acid and ether to extract the
volatile fatty acids. For each sample, 5 ml of the super-
natants was injected in a gas chromatograph (CP-3380;
Varian) equipped with a flame ionization detector and
connected to an integrator (model C-55A; Shimadzu). A
glass column (2m# 4mm) packed with 10% SP 1000 plus
1% H3PO4 on Chromosorb W AW (100/120 mesh) was
used. The instrument was operated at 170"C for 18min.
The operating conditions were as follows: injector tem-
perature, 200"C; detector temperature, 200"C; carrier gas
(nitrogen) flow rate, 30ml min$1. Each peak of the gas–
liquid chromatography patterns was identified by the re-
tention time compared with that obtained with standard
(2-methylpentanoic acid at 10mM). The amounts of fatty
acids were calculated by comparison with an internal
standard (34).
Microarray design, DNA-array hybridization
The microarray of C. difficile 630 genome was designed as
previously described (35) [Gene Expression Omnibus
(GEO) database accession number GPL10556].
Transcriptome was performed using four different RNA
preparations for each condition (JIR8094 in TY and
TYG, ccpA mutant in TY and TYG at 10 h of growth).
Labelled DNA hybridization to microarrays and array
scanning were done according to Saujet et al. (35). The
complete experimental data set was deposited in the GEO
database with a superseries record accession number
GSE35152.
Chromatin immunoprecipitation followed by microarray
hybridization (ChIP-on-Chip) experiments
The C. difficile strain 630 genome was obtained from
the European Molecular Biology Laboratory (EMBL)
database. Probe design for the microarray was performed
by using OligoArray 2.0 software (36). One to three oligo-
nucleotides were designed for each 3774 intergenic region,
including 100 bp of the 30 and 50 ends of genes edge. We
could not design oligonucleotides for 123 intergenic
regions. Probes were replicated twice on the Agilent
produced microarrays to reach a final density of 15 200
probes per array. A total of 459 positive controls and 77
negative controls were also included. The description of
the microarray design was submitted to the GEO database
(accession number GPL15104).
The chromatin immunoprecipitations (ChIP) were per-
formed using three independent cultures for each strain.
The C. difficile JIR8094 and its isogenic ccpA mutant
(negative control) strains were grown in TYG medium
until an optic density (OD)600 of 0.6 (37). The cells were
treated with formaldehyde (final concentration: 1%) and
incubated for 10min at 37"C. Cross-linking was quenched
by addition of glycine (final concentration: 400mM). Cells
were then collected by centrifugation, washed twice with
Tris-buffered saline (20mM Tris–HCl pH 7.5, 150mM
NaCl) and stored at $80"C. Pellets were resuspended in
10ml of buffer A [50 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES)–KOH pH 7.5,
150mM NaCl, 1mM ethylenediaminetetraacetic acid
(EDTA), 1% Triton X-100, 0.1% sodium dodecyl
sulphate (SDS), 0.1% sodium deoxycholate and
Complete antiprotease] and sonicated in a water bath
sonicator (Bioruptor, Diagenode) to shear DNA to an
average size of 400–600 bp. After centrifugation, the super-
natant was incubated for 3 h at 4"C in the presence of 40 ml
of Dynabeads
"
Pan mouse IgG (Life Technologies
TM
) on a
rotating wheel. Dynabeads were then removed
(non-specific immunoprecipitation), and supernatant was
incubated at 4"C overnight with polyclonal anti-CcpA
antibodies (1/500 dilution). The mixture was then
incubated with 50 ml of Dynabeads
"
Pan mouse IgG (Life
Technologies
TM
) for 90min at 4"C and washed twice with
buffer A, once with buffer A plus 500mMNaCl, once with
buffer B (10mM Tris–HCl pH 8.0, 1mM EDTA, 0.1%
Nonidet-P40,0.5% sodium deoxycholate) and once with
10mM Tris–HCl pH 7.5, 1mM EDTA. Antibodies
bound to the magnetic beads were then eluted for 20min
at 65"C with 100 ml of elution buffer (50mM Tris–HCl pH
7.5, 10mM EDTA, 1% SDS). Samples were then treated
with proteinase K (50mg) for 2 h at 56"C and 6 h at 65"C in
a 0.5# elution buffer. Immunoprecipitated DNA samples
were finally purified using the QIAquick polymerase chain
reaction (PCR) purification kit (QIAGEN). DNA
obtained from immunoprecipitation was then labelled
with Cy5 or Cy3 using the Bioprime plus array CGH
indirect genomic labelling system (Invitrogen) as recom-
mended by the manufacturer. Labelled DNA hybridiza-
tion to microarrays and array scanning were done
according to Saujet et al. (35). The complete experimental
data set were deposited in the GEO database with the ac-
cession number GSE34971.
Microarrays or ChIP-on-Chip data analysis
All the slides, from microarray or ChIP-on-Chip experi-
ment, were analysed using R and linear model for
microarray data software from Bioconductor project
(www.bioconductor.org). For each slide, we corrected
background with the ‘normexp’ method (38), resulting in
strictly positive values and reducing variability in the log
ratios for genes with low levels of hybridization signal.
Then, we normalized each slide with the ‘loess’ method
(39). To test for differential expression, we used the
Bayesian adjusted t-statistics, and we performed a
multiple testing correction of Benjamini and Hochberg
(40) based on the false discovery rate. For the transcrip-
tome data, a gene is considered as differentially expressed
when the P-value is <0.05. For the ChIP-on-Chip experi-
ment, a DNA region is considered as significantly enriched
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with a P-value <0.05. The enrichment factor for a given
intergenic region was calculated as the ratio of hybridiza-
tion of immunoprecipitated DNA in the JIR8094
compared with the ccpA mutant strains.
Bioinformatic analysis of CcpA binding regions
For the prediction of CcpA binding sites in C. difficile gen-
ome, we searched for a common motif in the promoter
region of 20 direct target genes identified in ChIP-on-Chip
experiments with a high ratio of enrichment (CD0201,
CD0279A, CD0395, CD0576, CD0833 CD1477,
CD1536, CD1768, CD1893, CD2241, CD2280, CD2327,
CD2347, CD2600, CD2625, CD2702, CD3218, CD3244,
CD3377, CD3664). The de novo motif extraction program
MEME (41,42) was used for the creCD motif identifica-
tion. A positional weight matrices (PWM)-based model
of the CcpA binding motif was generated and further
used for genome-wide detection of additional CcpA
targets in genomic upstream regions. The screening of
additional CcpA binding sites upstream of the genes
identified in the ChIP-on-Chip analysis and/or the CcpA
transcriptomic analysis was carried out using the
RegPredict web server (43). The motif was searched
in the leader regions from position $250 to+50 relative
to the translational start site for the MEME program and
$300 and+300 for RegPredict. Scores of candidate sites
were defined as the sum of positional nucleotide weights.
The score threshold for the search of candidate binding
sites was selected as a minimal score in the training set of
known CcpA target sites (score value 4.0). The details of
the identified CcpA taget binding sites and corresponding
genes are captured and displayed in the RegPrecise
database (regprecise.lbl.gov).
DNA techniques and electrophoretic mobility shift assay
DNA fragments containing the putative CcpA binding site
(creCD site) of genes CD0395, CD0833, CD1477, CD1536,
CD2327 and CD2600 were amplified by PCR from genomic
DNA of C. difficile 630 strain with primers OBD713–716,
OBD646–649, OBD678–681, OBD658–661, OBD706–709
and OBD664–667, respectively (Supplementary Table S1).
Deletion of the creCD site was performed on these amplified
DNA fragments as described in Supplementary Figure S1.
All PCR products were then used as templates to amplify
and to radioactively label a smaller DNA fragment of 200–
300bp containing or not containing the putative creCD site
with the corresponding primers listed in Supplementary
Table S1. The radioactively labelled DNA fragments cor-
respond to positions $97 to+82 with respect to the trans-
lational start site of CD0395, +213 to +434 of CD0833,
$146 to+75 of CD1477,+132 to+357 of CD1536, $215
to+73 of CD2327 and $183 to+22 of CD2600.
The other DNA fragments containing a creCD site of
genes CD0576 (position+44 to+300 with respect to the
translational start site), CD0659 ($338 to $168 and $220
to $52), CD0664 ($18 to+205), CD0770 ($3 to+179 and
+149 to+300), CD1214 ($107 to+106), CD1768 ($216 to
$6), CD1893 ($193 to +30), CD1935 ($267 to $58),
CD2241 ($197 to +46), CD2357 (+118 to +368),
CD3218 (+197 to +405), CD3244 ($385 to $197) and
CD3664 ($162 to+52) were amplified and radioactively
labelled by PCR from chromosomal DNA with corres-
ponding primers listed in Supplementary Table S1.
Promoter regions of CD1893 and CD3218 and internal
fragments of genes CD2327 and CD1477 without
putative creCD sites (negative controls) were also amplified
and radioactively labelled by PCR from chromosomal
DNA with primers OBD684–685 (position $193 to $43
with respect to the translational start site), OBD612–613
($117 to +84), OBD710–711 (+159 to +328) and
OBD704–705 (+57 to+208), respectively.
For the radioactive labelling of PCR fragments, all
forward primers were end-labelled with T4 polynucleotide
kinase (Fermentas and g-32P- adenosine triphosphate
(3000Ci.mM$1; Perkin Elmer) as recommended by the
manufacturer. After PCR, amplified labelled fragments
were then purified by QIAquick" Nucleotide Removal
kit (Qiagen
TM
). The labelled fragments were incubated
with increasing amounts of the purified CcpA–His6 at
room temperature for 15min in 20 ml of reaction volume
containing binding buffer (10mM Tris pH 7.5, 1mM
EDTA; 50mM KCl; 50 mg/ml bovine serum albumin,
0.05% Nonidet P-40, 10% glycerol, 1mM Dithiothreitol
(DTT), 10 mg/ml polydI-dC) as described in Antunes et al.
(30). Samples were loaded during electrophoresis onto a
5% non-denaturing polyacrylamide gel in Tris–glycine
buffer (25mM Tris–HCl pH 8, 190mM glycine, 1mM
EDTA) (30). After electrophoresis, the gel was dried and
analysed by autoradiography.
RESULTS AND DISCUSSION
Overview of the transcriptome data
The ability of bacteria to adapt to environmental changes
involves a number of physiological responses and complex
molecular regulatory circuits. In many pathogenic
bacteria, carbohydrate substrates constitute an important
signal used for compartment-specific modulation of viru-
lence genes during infection (44). Previously, we have
shown that glucose regulates C. difficile toxin genes ex-
pression through a direct binding of CcpA to the tcdA
and tcdB regulatory regions (30), suggesting that CcpA
seems to link virulence gene expression and carbohydrate
availability in this bacterium. However, a comprehensive
study of the role of CcpA in C. difficile physiology has not
been undertaken so far.
To determine the role of CcpA in CCR and the global
impact of glucose on gene expression, we performed a
transcriptional analysis of the wild-type strain JIR8094
and its isogenic ccpA mutant strain grown in TY or
TYG at the onset of stationary phase. Based on analysis
performed (TY versus TYG in JIR8094 or in ccpA and
ccpA versus JIR8094 in TYG or in TY), !21% of the
genes (782 genes) were differentially expressed with a
fold change %2 (Supplementary Table S2). In the
presence of glucose, !18% of the global genome (667
genes) was differently expressed in strain JIR8094.
Among them, 349 and 318 genes were up- and
downregulated, respectively (Table 1). As described in B.
subtilis and other Firmicutes, such as B. cereus or
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Streptococcus pyogenes (19,21,45), we observed that
C. difficile modulates a large number of genes in
response to glucose availability.
The CcpA regulon consists of !11% of all genes (407
genes, Table 1), and these results are in accordance to
what has been reported in other Firmicutes (17,20).
However, only 50% of the glucose-regulated genes are
controlled by CcpA in C. difficile in the conditions
tested, whereas in B. subtilis >80% of the genes are
controlled by CcpA in response to glucose (19). This in-
dicates the existence of still uncharacterized signalling
pathways that react to glucose in C. difficile. A total of
182 genes were regulated by glucose through a mechanism
that is fully or partially CcpA dependent. It is worth
noting that CcpA positively controls half of them in the
presence of glucose. Comparable observations have been
described for S. aureus (46). However, for most
Firmicutes, the number of genes repressed by glucose in
a CcpA-dependent manner largely exceeds the genes
activated by CcpA (17,20,45). Finally, we noted that the
expression of some genes was regulated by CcpA inde-
pendently of glucose. All genes differentially expressed in
response to glucose and/or controlled by CcpA are listed
in Supplementary Data (Supplementary Table S2). To
confirm the results obtained in the microarrays expression
data, we selected a subset of 15 representative genes of
different cell functions regulated by CCR and performed
quantitative reverse-transcriptase (qRT)-PCR with RNA
preparations from identical experimental conditions of the
transcriptome. qRT-PCR results confirmed array data for
majority of the tested genes (Supplementary Table S4).
In C. difficile, glucose and/or CcpA mainly regulate the
carbohydrate and energy metabolisms. Moreover, the
glucose adaptation response also implicates the regulation
of genes involved in carbon sources transport, amino acids
and peptide catabolism, stress response, sporulation,
proteins of the cell envelope, toxin synthesis and transcrip-
tional regulation. CcpA can control genes directly by
binding in the regulatory region of the controlled genes
or indirectly through other mechanisms (see later in the
text). To discriminate between these two possibilities, we
needed to identify the CcpA binding motif in C. difficile.
Identification of direct CcpA targets by ChIP-on-Chip
In B. subtilis, CcpA directly controls transcription of the
target genes by interacting with cre sites located within or
downstream from the promoter regions (47). Thus, we
first tried to identify the direct CcpA targets by screening
the genome for the B. subtilis cre consensus motif (creBS),
and we then compared the list obtained with that of genes
controlled by CcpA in transcriptome. However, we did
not find correlation between the presence of a creBS
motif and the CcpA-dependent control. Moreover, we
have previously demonstrated that the deletion of creBS-
like sites in the regulatory region of tcdA and tcdB does
not abolish CcpA binding (30). This strongly suggests that
the cre motif recognized by CcpA in C. difficile (creCD) is
significantly different of the creBS motif. To identify the
CcpA direct targets in vivo and define the creCD consensus
sequence, we performed ChIP-on-Chip experiments. For
this purpose, the C. difficile JIR8094 strain was grown in
TYG and then cross-linked with formaldehyde and
further immunoprecipitated with a specific anti-CcpA
antibody (30).
A total of 244 oligonucleotides were differentially
enriched in the presence of CcpA with a P-value of <0.05
and an enrichment factor %1.5. We identified 55 direct
targets of CcpA in vivo corresponding to !140 genes by
ChIP-on-Chip experiments (Table 2). Most of these genes
encode proteins involved in (i) fermentation, such as
acetoacetate production (scoB), hydrogen production
(hymB) and Stickland reactions (hadA and prdA); (ii)
energy metabolism (CD2429A, CD1170 and CD1807);
(iii) amino acids metabolism (CD1536, CD3664 and
gcvPB), including peptidases (CD0779 and CD2347)
and amino acid or peptide transporters (oppC, CD2173
and brnQ); (iv) PTS carbohydrate transporters and
associated enzymes involved in sugar utilization (CD0468,
CD0494, CD2280, gatA, celA and CD1336); and (v) non-
PTS sugar utilization (rbsR and CD1586), sialic acid deg-
radation (nanE) or ethanolamine transport (CD0742).
Genes implicated in sporulation, such as the major
response regulator Spo0A, were also directly controlled by
CcpA. Moreover, genes encoding six regulatory proteins,
and 12 proteins of unknown function have been identified
as direct CcpA targets. Among the targets depicted by the
ChIP-on-Chip experiments, 29 genes (53%) were regulated
by glucose and/or CcpA in transcriptome. The overlap of
genes identified in transcriptome and by ChIP-on-Chip
analysis is similar to that of other studies (48,49).
Table 1. Number of genes regulated by glucose and/or CcpA
Genes groupa Number of genesb
Glucose-dependent 667 (18%)
Upregulated genes 349
Downregulated genes 318
CcpA-dependent 407 (11%)
Upregulated by CcpA 197
Downregulated by CcpA 210
Regulated by glucose in a CcpA-dependent
manner
361 (10%)
Upregulated genes 170
Downregulated genes 191
Regulated by glucose in a CcpA-independent
manner
303 (8%)
Upregulated genes 177
Downregulated genes 126
Regulated by CcpA in absence of glucose 43 (1%)
Upregulated by CcpA 8
Downregulated by CcpA 35
Regulated by CcpA independent of glucose 3 (0.08%)
Upregulated by CcpA 2
Downregulated by CcpA 1
Atypical regulation 112 (0.3%)
Upregulated genes 39
Downregulated genes 73
Number of genes subject to regulation by glucose and/or CcpA in
in vitro growth conditions. The percentage of genes regulated was
calculated considering 3759 genes analysed in the transcriptome analysis.
aGroups partly overlap.
bA gene was considered to be regulated if transcription was induced or
repressed at least 2-fold (P< 0.05).
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Table 2. Direct CcpA targets identified by ChIP-on-Chip experiments
Gene Name FCa Oligonucleotide
50 position
Operon creCD motif Position
b Glucose
regulationc
CcpA
regulationc
CD0201 11 260578 CD0201 GAGAAAATGTTTACAG 77 NR NR
CD0279A or
CD0279
7.7 340693 AAGAAAACGTTATTAC $370 $ $
CD0298d rbsR 1.9 359108 CD0298–CD0302 AGTAAAACGGTTTCCT $28 $ $
CD0395e hadAe 7.1 467014 CD0395–CD0401 AGGAAAACGTTATGCT $12 $ $
CD0468 3 556433 CD0467–CD0469 TCAAAAAGATTTTCAT $255 NR NR
CD0494d 4 583410 CD0490–CD0494 AAGAAAACGTTAAGCA 26 NR NR
CD0530d 4.6 635577 CD0530–CD0528 AGGAAAACGTATTATA $78 NR NR
CD0576e virSe 33 687951 GAGAAAAGGATTTCTA 92 NR NR
CD0580d gapN 2.1 692989 AGAAAAACGTTAACTT $124 NR NR
CD0679d 4 821606 ATGATAACATTTTCTT $169 NR NR
CD0742 6.5 905449 CD0741–CD0742 GGGAAAACGATACCAA $76 NR NR
CD0779d 1.7 949162 CD0778–CD0780 GAGAAAAAGACATCAT 50 $ NR
CD0833e acnBe 9.7 1009212 CD0832–CD0834 AGGAAATGGTATTTGT 284 $ $
CD0854d oppC 5.7 1029471 CD0853–CD0856 AAGAAAACCTTATCTA 77 $ $
CD1116 36 1312695 GAGAAAAGGTTTCCAA 167 NR +
CD1137 5.2 1336232 CD1136–CD1137 GAAAAAATGTTTTTTT $37 NR NR
CD1170 5.9 1368750 CD1170–CD1173 ND ND + NR
CD1214e spo0Ae 1.5 1412498 TGTAAAAAGTTTAGTT $42 $ $
CD1321d 1.6 1531839 AGGAAATAGTTAACTT 24 $ $
CD1336 1.5 1550212 TAGAAAACGTTTTAAA $41 NR NR
CD1385 3.6 1603687 CD1384–CD1387 AAGAAAGCGTTTTGAA $111 $ $
CD1477e feoAe 13 1714290 CD1477–CD1480 AAGATAACGATTGCTT $52 NR +
CD1536e 15.5 1781719 CD1536–aspB AAGAAAACGATTTTGT 231 NR $
CD1586 6.6 1838850 CD1584–CD1589 TAGAAAAGGTTATCAT 111 + NR
CD1599 thiD 3.8 1854754 CD1599–CD1601 TTGAAAACGTTTAGTG 76 NR –
CD1658 gcvPB 1.8 1925192 CD1657–CD1658 AGGAAATAGATAAGTT $40 $ $
CD1768d,e 10 2045870 GAGAAAAGGTTTTGTT $93 + +
CD1807 3.2 2091015 ND ND $ $
CD1893d,e 6.8 2198560 TATAAAACGTTTTCTT $75 NR NR
CD1935d,e spoVSe 1.8 2233439 AAATAAAGGTTTTCTT $142 NR $
CD2111d 6 2440328 TAGAAAATGTTTGCAG $7 NR NR
CD2173 1.8 2515137 CD2177–CD2172 GAGAAAAAATTATAAA 56 $ $
CD2241d,e nanEe 7.8 2592979 CD2241–CD2239 AAGAAAAAGTTTTCAT $72 NR NR
CD2280d 4.5 2646506 CD2282–CD2279 AAGAAATCGTTTCTTT 100 NR NR
CD2327d,e gatAe 30 2689528 CD2327–CD2325 GGGAAAACATTTTCTT $113 $ $
CD2344 1.7 2714126 CD2344–CD2341 AAGATAAAATTTTTTT $152 $ $
CD2347 8 2716984 CAGAAAAGGTTTGCAA 176 + +
CD2429A or
CD2429d
11 2804869 CD2429A–CD2427 GAGAAAAGGTATGCAA $9 or 217 NR NR
CD2481d ung 3.6 2863759 CD2482–CD2481 TTGAAAAAGATTACTA 47 NR NR
CD2600e cstAe 5.5 3009085 TGGAAATAGTTTTCTT $67 NR NR
CD2625d 4.4 3031999 AGGATAACGTTATCAT $61 NR NR
CD2626d 6 3034769 CD2627–CD2626 GAGAAAAAATATACAA 131 NR NR
CD2678 scoB 15 3093914 CD2676–CD2679 ATGTAAACGTTATCTT 120 NR NR
CD2693 1.5 3113024 AAGAAAAAAATAGGTT 4 $ $
CD2702 brnQ 4.5 3124254 GGGAAAACGTTAACAA $104 $ NR
CD2879 3.8 3368263 TAGATAAGGTTTTCTT $128 NR NR
CD2884d celA 1.6 3372956 CD2884–CD2880 ATGAAAAAGTTTTCTT $186 NR NR
CD3175d cggR 1.5 3711205 AGGAGAACATTATCAA 109 + $
CD3184 dpaL 8.5 3726740 TAGATTTGGTTTAAAT 206 NR NR
CD3218e 5 3766712 GAGTTAACGTTTTCAA 254 + $
CD3244d,e prdAe 6.5 3796160 CD3244–CD3236 GAGAAAATGTTTACAA $293 + +
CD3377 mgtA 7.4 3950193 CD3377–CD3376 ND ND NR +
CD3406d hymB 3 3984409 CD3405–CD3407 CTGATAACGTTTTCTA 270 NR NR
CD3649 rlmH 13 4258421 AAGAAAAGGCTTTCTA 70 NR NR
CD3664e 30 4275636 AAGAAAACATTTTCAT $30 NR NR
aFold Change (FC) corresponding to enrichment factor in ChIP-on-Chip experiments.
bcreCD motif position from ATG start codon. ND=not detected.
cGene regulation resulting from transcriptome and qRT-PCR analysis. ‘–’ for downregulation, ‘+’ for upregulation and ‘NR’ for absence of
regulation. For more details, see Supplementary Table S2.
dIndicates the existence of a second putative creCD motif.
ecreCD sites confirmed by EMSA experiments.
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In silico definition of a creCD consensus
The region of C. difficile genes determined as direct CcpA
targets by ChIP-on-Chip experiments with an enrichment
factor >5 was searched for common CcpA binding sites to
define the creCD motif using the MEME software.
A conserved 16-bp pseudopalindromic motif (RRGAAA
ASGTTTTCWT, where R stands for adenine or guanine,
S stands for guanine or cytosine and W stands for adenine
or thymine) was identified in the upstream regions of 12
CcpA target genes. Then, we used this motif and the
RegPredict web server (43) to search for similar CcpA
binding sites for all genes identified by the
ChIP-on-Chip experiment. Among the 55 CcpA direct
target genes, we failed to identify a creCD motif for only
three genes (CD1170, CD1807, CD3377), despite the fact
that CD1807 and CD3377 were controlled by CcpA in
transcriptome (Table 2). This could be explained by a de-
generation of their binding sites as proposed for some
targets of the Escherichia coli NsrR repressor identified
in vivo using ChIP-on-Chip technology (48).
Interestingly, for some target sites that reside inside of
operons, we observed a clear correlation between the
position of the oligonucleotides bound by CcpA in
ChIP-on-Chip and the location of a putative creCD site.
This is the case for acnB, oppC, CD1385, gcvPB, scoB,
CD2626 and hymB (Table 2). The alignment of all
probable CcpA binding motifs listed in Table 2 allows
the establishment of a creCD consensus (Figure 1). The
creCD motif identified in this work for C. difficile has
limited similarity with the cre consensus previously
identified in various bacteria from the bacilli class of
Firmicutes including Bacillus, Lactococcus, Enterococcus
and Streptococcus species (20,21,47,50). Besides the
guanine and the cytosine at 3rd and 14th positions, re-
spectively, which are identical in both motifs, the creCD
consensus is not similar to the creBS motif (Figure 1).
Importantly, the creCD motif lacks the essential central
CG bases (16) present in the creBS consensus
(WTGNNARCGNWWWCAW). These observations cor-
relate with the weak similarities of CcpA helix-turn-helix
(HTH)-DNA binding domain from these bacteria (47%
identity), whereas, for instance, the HTH motif of CcpA
of L. lactis has 70% identity with that of B. subtilis, and
both have similar cre sites.
CcpA directly binds to the creCD motif of genes identified
by ChIP-on-Chip
To validate the ChIP-on-Chip experiment and confirm the
role of the creCD site in the CcpA binding activity, elec-
trophoretic mobility shift assays (EMSAs) were performed
using purified C. difficile CcpAHis6 (30) and DNA frag-
ments containing a putative creCD site of 15 CcpA
targets (Table 2). The CcpA transcriptional regulator
induced a shift in mobility of DNA fragments containing
a creCD site of all genes tested (CD1893, spoVS, nanE,
CD3218, CD3664, virS, CD1768, spo0A, prdA, hadA,
feoA, gatA, acnB, CD1536 and cstA) (Figures 2 and 3).
However, the concentration of CcpA required to obtain a
full shift differed depending on the target genes. To dem-
onstrate the specificity of CcpA binding to the creCD
site-containing DNA fragments, we first showed that no
shift was induced by CcpA with promoter regions of
CD1893 and CD3218 or with internal DNA fragments
of feoA and gatA that do not contain a creCD site
(Figures 2D and 3C). Moreover, the formation of the
CcpA–DNA complex was prevented by the addition in
excess of unlabelled DNA fragments containing the
creCD site of acnB, CD1893 and CD3218 used as a com-
petitor (data not shown). These results validated the
binding of CcpA to the targets identified by ChIP-on-
Chip, including those with low-enrichment factors like
spo0A or spoVS, and showed the specific interaction of
CcpA with creCD sites.
To further demonstrate that the creCD site alone is
required for the binding of CcpA, we performed EMSAs
using DNA fragments deleted or not for the creCD site of
the hadA, acnB, feoA, CD1536, gatA and cstA genes. As
shown in Figure 3, the deletion of the creCD site abolished
the shift induced by CcpA for the regulatory regions
tested. We confirm that CcpA can interact in vitro with
the creCD site-containing DNA fragments of 15 genes, and
we show that this binding disappears when the creCD site is
deleted for six genes. Interestingly, CcpA interacts in vivo
with creCD sites that are located inside of operons, and we
clearly demonstrate that in the case of acnB, this creCD
sequence is recognized and bound by CcpA in vivo
(ChIP-on-Chip) and in vitro (EMSA) leading to the
strong repression of the aksA-acnB-icd operon by CcpA.
This site internal to an operon is functional as previously
shown for the iol operon of B. subtilis (51).
Identification of additional candidates for a direct
CcpA control
Using the RegPredict web server (43), we extended the
search of the creCD motif to the complete C. difficile
genome of strain 630. We detected 901 putative creCD
sites corresponding to 783 genes with a score >4,
located between position $300 to+300 from the transla-
tional start sites (Supplementary Table S3). This in silico
analysis allowed us to identify 143 putative creCD sites
corresponding to about half of the CcpA-controlled
genes in transcriptome (Supplementary Table S2). Most
of these sites are adjacent or inside genes involved in
carbon and energy metabolisms (35 genes), in amino
acids biosynthesis or degradation (31 genes), in sporula-
tion (7 genes), in regulation (10 genes), in cell envelope
(10 genes) or encoding proteins of unknown function
(29 genes).
To show whether at least some of these predicted creCD
sites are functional, we performed EMSAs with creCD
site-containing DNA fragments of two genes (spoIIAA
and grdX) negatively regulated by CcpA in transcriptome,
but not retained by CcpA in our ChIP-on-Chip experi-
ment conditions (Supplementary Table S2). A shift of a
DNA fragment containing the creCD motif at position
+198 relative to the translational start site of grdX was
observed in the presence of 97 nM of CcpA (Figure 4A).
This interaction disappeared in the presence of an excess
of the same unlabelled DNA fragment (data not shown).
For the spoIIAA gene, two different creCD sites located at
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position +87 and +194 from the translational start site
were found with RegPredict. We showed that 388 nM of
CcpA induced a shift with the DNA fragment containing
the site at position+87 (Figure 4B) and not with a DNA
fragment containing the site at position +194 (data not
shown). However, when we performed EMSA with a
DNA fragment containing both creCD sites, 97 nM of
CcpA was sufficient to induce a shift (data not shown).
These results indicated that the binding affinity of CcpA
to the spoIIAA regulatory region increased when both
creCD sequences are present. Thus, despite the fact that
we did not see the binding of CcpA to the spoIIAA and
grdX genes in the ChIP-on-Chip conditions used, these
genes could also be direct physiological CcpA targets.
This suggests that CcpA might directly control additional
genes with creCD motifs deduced from the in silico search.
Interestingly, five putative creCD sequences are detected
in the PaLoc as follows: upstream of the translational start
site of tcdR (positions $235 and $169) or tcdB (position
$211) and inside the tcdA gene (position +277) or tcdC
gene (position+58). The binding of CcpA to the promoter
region of tcdB and to the 50 end of the tcdA gene, which
has been already demonstrated (30), is consistent with the
position of the creCD motif. Thus, we tested the possible
interaction of CcpA with the creCD sites of the promoter
region of tcdR and of the 50 end of the tcdC gene. We
detected a shift with the creCD site-containing fragment
of tcdC in the presence of 97 nM of CcpA (Figure 4A).
We also observed the formation of a protein–DNA
complex with a DNA fragment containing the two
putative creCD sites of tcdR when we used 65 nM of
CcpA, whereas 388 nM was needed for a shift of
the DNA fragment containing only one of each site
(Figure 4B) suggesting a cooperative effect of the creCD
sites. Therefore, with the exception of tcdE, CcpA inter-
acts with the promoter region or with the 50 end of the
PaLoc genes. These results show the complex regulation of
toxin synthesis in response to glucose availability
mediated by CcpA.
Role of glucose and CcpA in the control of C. difficile
carbohydrate metabolism
In this work, we used genome-wide transcriptome,
ChIP-on-Chip experiments and in silico analysis to char-
acterize the CcpA regulon. We discussed later in the text in
more details the involvement of glucose and CcpA in the
global control of key metabolic pathways and cellular
processes of C. difficile.
Compared with other pathogenic clostridia, C. difficile
has a larger repertoire of EII PTS (51 PTS in strain 630),
and this bacterium is able to ferment several sugars taken
up by PTS, such as fructose, glucose, mannitol and
mannose (52). In the presence of glucose, we found that
C. difficile preferentially expresses glucose (CD2667–
CD2666), fructose (CD2486–CD2488) and mannose
(CD3015–CD3013) PTS, whereas the synthesis of some
PTS of secondary carbon sources, such as sorbitol
(CD0764–CD0768), galactitol (CD2327–CD2325) or
cellobiose (CD3089–CD3088), was repressed by glucose
(Figure 5). All PTS transporters induced by glucose were
regulated by CcpA. Among the PTS systems repressed by
glucose, only the galactitol PTS was controlled by CcpA.
We further demonstrated by qRT-PCR that during expo-
nential growth, the expression of the gatABC operon was
strongly repressed by glucose through CcpA (Supple-
mentary Figure S2). The expression of the rbsRKBAC
(CD0298–CD0302) operon encoding the ribose repressor,
a ribose ABC transporter and the ribokinase was re-
pressed by glucose in C. difficile. Moreover, when we
looked at the rbsR expression at mid-exponential growth
phase by qRT-PCR analysis, we observed that rbsR ex-
pression was partially repressed by CcpA in response to
glucose (Supplementary Figure S2). We demonstrated in
ChIP-on-Chip experiment that the rbs operon and genes
encoding cellobiose or galactitol PTS (CD2884-CD2880
and CD2327-CD2325) and two other PTS systems
(CD0467–CD0469 and CD0490–CD0494 operons) were
direct CcpA targets (Table 2 and Figure 3A). Only a few
PTS and non-PTS sugar utilization systems were regulated
by glucose and/or CcpA in transcriptome in the conditions
we used. However, other genes involved in sugar assimi-
lation systems were bound by CcpA in ChIP-on-Chip. We
cannot exclude that genes involved in carbohydrate util-
ization are not detected in transcriptome, as they are ex-
pressed at basal level in the absence of sugar inducers.
After sugar uptake, the carbohydrates are metabolized
through the central carbon metabolism to produce energy
and precursors for anabolism. Glucose addition regulates
several pathways of the central carbon metabolism, such
as glycolysis, gluconeogenesis and pentose-phosphate
pathway (PPP) in C. difficile. The expression of fba
encoding the fructose-1,6-bisphosphate aldolase, a key
Figure 1. C. difficile creCD consensus of the CcpA binding motif. The motif sequence logo was created based on the alignment of all the proposed
direct targets of CcpA listed in Table 2, using the weblogo website (http://weblogo.berkeley.edu). The height of the letters is proportional to their
frequency.
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enzyme of glycolysis, was strongly induced by glucose and
positively regulated by CcpA (Figure 5). However, most
genes encoding for the central glycolysis/gluconeogenesis
pathway were regulated by glucose independently of
CcpA. In fact, the gapA-pgk-tpi-gpmI-eno operon
(CD3174–CD3170) was strongly induced by glucose,
whereas the expression of gapB (CD1767) and fbp
(CD1191) was repressed. Likewise, in B. subtilis, the
expression of the gapA operon is induced by glucose,
whereas the gapB and pckA genes involved in
gluconeogenesis are repressed by glucose through a
CcpA-independent mechanism (18). The PPP is an alter-
native route of glucose degradation that generates nico-
tinamide adenine dinucleotide phosphate (NADPH) and
pentoses (Figure 5). Among the genes involved in
this pathway, synthesis of the transketolase from the tkt’
and tkt genes (CD2321, CD2322) and the ribose-5-P isom-
erase from rpiB2 (CD3480) was induced by glucose in
Figure 2. Binding of CcpA to different targets with a putative creCD sequence identified by ChIP-on-Chip experiments. EMSAs of DNA fragments
containing the creCD binding sites of the CD1893, spoVS (CD1935), nanE (CD2241), CD3218, CD3664, virS (CD0576), CD1768, spo0A (CD1214)
and prdA (CD3244) genes. The 32P-labelled DNA fragments were incubated with increasing concentrations of purified CcpA–His6 as described in the
‘Materials and Methods’ section: (A) 0, 32, 65, 97 and 129 nM of CcpA–His6; (B) 0, 97, 129, 194 and 259 nM of CcpA–His6; (C) 0, 129, 259, 388 and
518 nM of CcpA–His6. (D) Negative controls corresponding to the DNA fragments containing promoter regions of CD1893 and CD3218 without
putative creCD sites were incubated with 0, 65, 97 and 129 nM of CcpA–His6, and 0, 97, 129, 194 and 259 nM of CcpA–His6, respectively. The
autoradiograms of the gels are shown. F= free DNA; C=protein–DNA complex.
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Figure 3. Impact of creCD deletion on the binding of CcpA to the hadA, acnB, feoA, CD1536, gatA and cstA target genes. EMSAs of DNA
fragments containing the creCD binding site (creCD) or the same DNA fragment where the creCD site has been deleted (!creCD) of the hadA
(CD0395), feoA (CD1477), gatA (CD2327), acnB (CD0833), CD1536 and cstA (CD2600) genes. The 32P-labelled DNA fragments were incubated
with increasing concentrations of purified CcpA–His6 as described in the ‘Materials and Methods’ sections: (A) 0, 13, 32 and 65 nM of CcpA–His6;
(B) 0, 65, 97 and 129 nM of CcpA–His6. (C) Internal
32P-labelled DNA fragments of feoA and gatA genes without putative creCD sites were
incubated with 0, 65, 97 and 129 nM of CcpA–His6 (negative controls). The autoradiograms of the gels are shown. F: free DNA; C: protein–
DNA complex.
Figure 4. Binding of CcpA to the creCD sites of tcdC, grdX, tcdR and spoIIAA target genes. EMSAs of DNA fragments containing the creCD sites of
the tcdC (CD0664), grdX (CD2357), tcdR (CD0659) and spoIIAA (CD0770) genes. The 32P-labelled DNA fragments were incubated with increasing
concentrations of purified CcpA–His6 as described in the ‘Materials and Methods’ section: (A) 0, 32, 65, 97 and 129 nM of CcpA–His6 for tcdC and
grdX; (B) 0, 129, 259, 388 and 518 nM of CcpA–His6 for tcdR-creCD1,tcdR-creCD2 and spoIIAA and 0, 65, 97, 129, 259, 388 and 518 nM of CcpA–
His6 for tcdR-creCD1-CD2. The autoradiograms of the gels are shown.
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Figure 5. Role of glucose and CcpA in the regulation of carbohydrate utilization, central carbon metabolism and fermentation. Genes encoding
enzymes or transporters, which are regulated by CcpA and/or glucose in transcriptome. Green: gene downregulated by glucose; red: gene upregulated
by glucose; black: gene not regulated by glucose; blue CcpA: regulation by glucose through CcpA; blue and underlined CcpA: other type of control
by CcpA; perpendicular: gene downregulated by CcpA; arrow: gene upregulated by CcpA. glgCDA (CD0882–CD0884), glycogen biosynthesis; fbp
(CD1191), fructose-1,6-bisphosphatase; fba (CD0403), fructose-1,6-bisphosphate aldolase; tpi (CD3172), triosephosphate isomerase; gapA (CD3174)
and gapB (CD1767), glyceraldehyde-3-phosphate dehydrogenase; pgk (CD3173), phosphoglycerate kinase; gpmI (CD3171), 2,3-bisphospho-
glycerate-mutase; eno (CD3170), enolase; pykF (CD3394), pyruvate kinase; fumB (CD1004), fumarate hydratase subunit B; CD1005, putative nico-
tinamide adenine dinucleotide-dependent malic enzyme; rpe (CD2319), putative ribulose-phosphate 3-epimerase; rpiB1 (CD2320), ribose-5-phosphate
isomerase B1; rpiB2 (CD3480), ribose-5-phosphate isomerase B2; rbsK (CD0299), ribokinase; tkt’ (CD2321), transketolase, central and C-terminal;
tkt (CD2322), transketolase, N-terminal; CD0764–CD0768, PTS sorbitol IIC, IIB, IIA; CD3089–CD3088, PTS cellobiose IIBC; CD2327–CD2325,
PTS galactitol IIA, IIB, IIC; CD0208–CD0206, PTS fructose-like IIA, IIB, IIC; CD2486–CD2488, PTS fructose-like IIC, IIB, IIA; CD3015–
CD3013, PTS mannose-specific IIA, IIB, IIC; ptsG (CD2667, CD2666), PTS glucose-specific IIA, IICB; pmi (CD2491), mannose-6-phosphate
isomerase; rbsBAC (CD0300–CD0302), ribose ABC transporter; adhE (CD2966) and CD3006, aldehyde-alcohol dehydrogenase; thlA (CD1059),
acetyl-CoA acetyltransferase; hbd (CD1058), 3-hydroxybutyryl-CoA dehydrogenase; crt2 (CD1057), 3-hydroxybutyryl-CoA dehydratase; cat1
(CD2343), succinyl-CoA: coenzyme A transferase; sucD (CD2342), succinate-semialdehyde dehydrogenase; 4hbd (CD2338), 4-hydroxybutyrate de-
hydrogenase; cat2 (CD2339), 4-hydroxybutyrate CoA transferase; abfD (CD2341), vinylacetyl-coa-d-isomerase; bcd2 (CD1054), butyryl-CoA de-
hydrogenase; etfBA (CD1055–CD1056), electron transfer flavoproteins; ptb (CD0715, CD0112), phosphate butyryltransferase; buk (CD0113),
butyrate kinase.
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strain JIR8094 (Figure 5). In B. subtilis and S. aureus, only
the gluconate conversion enzymes of the PPP to provide
ribulose 5-P are weakly induced by glucose (18,46).
Glucose and/or CcpA regulate the synthesis of several
other enzymes involved in carbon metabolism. The aksA-
acnB-icd operon (CD0832–CD0834), which encodes a
trans-homoaconitate synthase, an aconitate hydratase
and an isocitrate/3-isopropylmalate dehydrogenase, re-
spectively, was strongly repressed by glucose through
CcpA. As mentionned previously, we found a creCD site
inside acnB, and we showed that it is a direct CcpA target
in vivo (Table 2) and in vitro (Figure 3B). Moreover, ex-
pression of fumB (CD1004) involved in malate formation
from fumarate and of a gene encoding a protein sharing
57% identity with YtsJ of B. subtilis involved in malate to
pyruvate interconversion (CD1005) was induced by
glucose in a CcpA-dependent manner (Figure 5, Supple-
mentary Table S2). However, these genes lack creCD sites,
therefore, suggesting an indirect effect of CcpA. Finally,
the pyruvate carboxylase pycA gene (CD0021) leading to
oxaloacetate production from pyruvate was induced in the
presence of glucose by a CcpA-independent mechanism.
The role of glucose and CcpA in the regulation of energy
metabolism
The principal source of energy in C. difficile comes from
the catabolism of carbohydrates and amino acids.
Clostridium difficile metabolizes carbohydrates through
fermentation, leading to the production of short-chain
fatty acids (lactate, acetate, butyrate, propionate . . . ) and
minor quantity of alcohols (12,53). The pathways allowing
the synthesis of butyryl-CoA from acetyl-CoA (CD1054–
CD1059) or succinate (CD2344–CD2338) and the further
production of butyrate (CD0112–CD0113) or butanol
(CD2966) from butyryl-CoA were repressed by glucose
through a CcpA-dependent mechanism (Figure 5,
Supplementary Tables S2 and S4). Among these genes,
creCD sites are present inside the bcd2 operon (CD1054–
CD1059) and upstream of CD2344 and adhE (CD2966)
(Figure 5 and Supplementary Table S2).
To confirm the impact of glucose addition and CcpA
regulation on the fermentation processes, we analysed by
gas–liquid chromatography the end products of fermenta-
tion of strain JIR8094 and the ccpA mutant grown in TY
or in TYG. We could not detect butanol nor ethanol by
these assays. The formation of butyric, isobutyric, valeric,
propionic and isoheptanoic acids was repressed by
glucose, and this downregulation was fully or partially
abolished in a ccpA mutant in TYG (Figure 6). These
results are in agreement with our transcriptome data,
indicating that key steps of fermentation are repressed
by glucose through CcpA. It is intriguing to note that
the ccpA gene disruption led to a decreased production
of the end products of fermentation in the absence of
glucose. This effect could result from a change in the me-
tabolism balance because of the lack of CcpA, to an
indirect influence of CcpA in the fermentation pathways
Figure 6. Fermentation end products of the strain JIR8094 and the ccpA mutant grown in the presence or absence of glucose. Gas–liquid chro-
matography analysis of the metabolic end products from JIR8094 and DccpA mutant strains after 48 h of growth in TY or TYG medium was
performed. The mean and standard error of three experiments are shown. Asterisk corresponds to significative statistical difference analysed by the
student t-test (P< 0.05).
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through the modulation of intracellular concentration of
metabolites or a cascade of regulation by uncharacterized
mechanisms.
Clostridium difficile can also use amino acids as energy
sources through Stickland reactions. These reactions
consist in the coupled fermentation of two amino acids,
in which one is oxidatively deaminated or decarboxylated
(Stickland donor) and another is reductively deaminated
or reduced (Stickland acceptor). The most efficient
Stickland donors are valine, leucine, isoleucine and
alanine, whereas the most efficient acceptors are proline,
glycine and leucine (54,55).
The expression of prdE, prdF and prdA genes (CD3237,
CD3239 and CD3244), required for proline reduction, was
induced by glucose and positively controlled by CcpA
(Figure 7, Supplementary Table S2 and Figure S2).
Actually, prdA harbours a creCD site in the promoter
region to which CcpA was able to bind in vivo and in
vitro (Table 2 and Figure 2C). The expression of ldhA,
hadA, hadI, acdB and etfB1 genes (CD0394, CD0395,
CD0396, CD0399 and CD0400) required for the leucine
reductive branch leading to the formation of isocaproate
was 4-fold repressed by glucose by a CcpA-dependent
mechanism (Figure 7). We also identified hadA as a CcpA
direct target by ChIP-on-Chip analysis (Table 2) and
demonstrated that the creCD site located upstream of
hadA was essential for CcpA binding, as its deletion no
longer showed a shift by EMSA analysis (Figure 3A).
Figure 7. Role of glucose and CcpA in the control of peptide and amino acid metabolisms. Genes encoding enzymes or transporters, which are
regulated by CcpA and/or glucose in transcriptome. Green: gene downregulated by glucose; red: gene upregulated by glucose; black: gene not
regulated by glucose; blue CcpA: regulation by glucose through CcpA; blue and underlined CcpA: other type of control by CcpA; hash: localization
unknown; perpendicular: gene downregulated by CcpA; arrow: gene upregulated by CcpA. lysC (CD2054), aspartokinase; asd (CD3224),
aspartate-semialdehyde dehydrogenase; dapA1 (CD3000), dihydrodipicolinate synthase 1; dapA2 (CD3223), dihydrodipicolinate synthase 2; dapA3
(CD3225), dihydrodipicolinate synthase 3; dapB1 (CD3226), dihydrodipicolinate reductase; dapH (CD3227), 2,3,4,5-tetrahydropyridine-2,6-
dicarboxylate; lysA (CD2053), diaminopimelate decarboxylase; thrC (CD2118), threonine synthase, thrB (CD2119), homoserine kinase; tdcB
(CD2514), threonine dehydratase II; serA (CD0995), putative D-3-phosphoglycerate dehydrogenase; sdaB (CD3222), L-serine dehydratase; cysE
(CD1595), serine acetyltransferase; cysK (CD1594), O-acetylserine sulphydrylase; iscS2 (CD1279), cysteine desulphurase; oppBCADF (CD0853–
CD0857), oligopeptide ABC transporter; CD2177–CD2174, cystine ABC transporter; prdF (CD3237), proline racemase; prdE (CD3239), proline
reductase; prdA (CD3244), D-proline reductase proprotein; prdB (CD3241), proline reductase; trxB3 (CD2356), thioredoxin reductase 3; trxA2
(CD2355), thioredoxin 2; grdX (CD2357), glycine reductase complex component; grdE (CD2354), glycine reductase complex component B
subunits a and b; grdA (CD2352), glycine reductase complex selenoprotein A; grdB (CD2351), glycine reductase complex component B g
subunit; grdC (CD2349), glycine reductase complex component C subunit b; grdD (CD2348), glycine reductase complex component C subunit a;
ldhA (CD0394), 2-hydroxyisocaproate dehydrogenase; hadA (CD0395), 2-hydroxyisocaproate CoA transferase; hadI (CD0396), activator of
dehydratase; acdB (CD0399), acyl-CoA dehydrogenase; gcvTPA (CD1657), bi-functional glycine dehydrogenase/aminomethyl transferase protein;
gcvPB (CD1658), Glycine decarboxylase; CD1228, putative protease; CD3183, putative peptidase; CD2485, putative Xaa-Pro aminopeptidase;
CD2347, putative Xaa-Pro dipeptidase; gcp (CD0152), putative O-sialoglycoprotein endopeptidase; CD2129, putative membrane-associated peptid-
ase; pepI (CD3041), proline iminopeptidase.
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Finally, most of the genes of the trxA2-trxB3-grdXEABCD
operon involved in glycine reduction (CD2358–CD2348)
and gcv operon involved in glycine oxidation (CD1657–
CD1658) were repressed by CcpA in reponse to glucose
(Figure 7) (56). Moreover, CcpA binds to the creCD motif
internal to grdX (CD2357) (Figure 4A) and a creCD site is
present upstream of gcvPB (CD1658) (Table 2). Despite the
fact that the utilization of serine to produce energy has not
been described in C. difficile, this amino acid is preferen-
tially degraded with threonine, arginine, cysteine and
proline by Clostridium sticklandii that is closely related to
C. difficile. Interestingly, the expression of sdaB (CD3222)
involved in serine degradation to form pyruvate that can be
further metabolized by fermentation was induced by
glucose and positively controlled by CcpA (Figure 7).
Thus, CcpA seems to play a key role in the hierarchy of
amino acid utilization in C. difficile. It directly regulates
the genes involved in Stickland reactions by using prefer-
entially proline as an energy source in detriment of leucine
or glycine. It is worth adding that addition of proline
represses toxin synthesis, whereas genes encoding enzymes
for the reductive pathway of glycine and leucine are
upregulated during growth conditions that favour toxin
production (57). This observation suggests a connection
between proline utilization and the control of toxin syn-
thesis that probably involves a regulation by CcpA.
Amino acids metabolism
In C. difficile, the synthesis of several proteases and pep-
tidases was regulated by CcpA in response to glucose
(Figure 7). Among them, the expression of gcp
(CD0152) encoding an O-sialoglycoprotein endopeptidase
and three other peptidases encoding genes (CD1228,
CD2129 and CD3183) was induced by glucose in a
CcpA-dependent manner. Similarly, the same type of
regulation was found for the proline iminopeptidase
gene pepI (CD3041) and peptidases encoding genes
(CD2347 and CD2485) that share similarities with
Xaa-Pro dipeptidases. So, we observed a coordinated
regulation of the peptidases (release of free proline) and
the proline reductase encoding genes (54). By contrast, the
expression of the oppBCADF operon (CD0853–CD0857)
encoding an oligopeptides ABC transporter was repressed
by glucose through a CcpA-dependent mechanism.
Furthermore, CD2347 and oppBCADF operons are
CcpA direct targets bound by CcpA in vivo and harbour-
ing a creCD site (Table 2).
In C. difficile, the glucose induces the biosynthetic
pathways of lysine, threonine, serine and cysteine, and
CcpA plays a role in the control of some of them
(Figure 7, Supplementary Table S2). The expression of
asd-dapA3-dapB1 and dapH (CD3224–CD3227) involved
in lysine biosynthesis from aspartate was positively
controlled by CcpA in response to glucose availability
(Figure 7). Expression of the cysK-cysE (CD1594–
CD1595) and the iscR-iscS2-iscU (CD1278–CD1280)
operons involved in cysteine synthesis and iron–sulphur
biogenesis from cysteine (sulphur donor), respectively,
was increased in the presence of glucose independently
of CcpA (Figure 7, Supplementary Table S2). Thus, in
the presence of glucose, the increased expression of
pathways required for iron-sulphur production might be
related to the crucial role of iron–sulphur proteins in
electron transfer and fermentation pathways (58). In con-
clusion, we show that CcpA in C. difficile is not only
involved in the control of carbon metabolism but is also
implicated in the regulation of nitrogen metabolism as
described for B. subtilis (17).
Control of stress response and cell wall metabolism by
glucose and CcpA
During host infection, C. difficile is exposed to several
stresses and responds by inducing different mechanisms
of defense, such as the synthesis of the heat shock
proteins (Hsps), which are also induced by acid and oxi-
dative stresses in C. difficile (59). We observed that CcpA
regulated the expression of genes involved in heat stress
response in the presence of glucose likely through an
indirect control, as we did not detect creCD sites
upstream of these genes (Supplementary Table S2). The
expression of certain genes implicated in oxidative stress,
such as norV, encoding a protein involved in nitric oxide
(NO) detoxification, and trxB (CD1691), encoding a
thioredoxin reductase was induced by glucose through
CcpA. Furthermore, the presence of a creCD site in norV
(CD1157) indicated that this gene is probably directly
regulated by CcpA (Supplementary Table S2). The in-
volvement of CcpA in the regulation of stress proteins
has also been reported in Lactobacillus plantarum (60)
and in Enterococcus faecalis (61).
Previous studies showed the involvement of cell surface-
associated proteins in C. difficile colonization (5). We
observed that CcpA in response to glucose or CcpA
alone was implicated in the control of a large number of
genes encoding cell wall proteins and peptidoglycan
hydrolases potentially implicated in C. difficile adhesion
to the host cells (Supplementary Table S2). Moreover, a
creCD site is present in the dltDABC operon that was re-
pressed by CcpA (Supplementary Table S2). This operon
encodes for proteins responsible for the teichoic acids
D-alanylation, playing an important role in the bacterial
autolytic activity (62). In S. pneumoniae, CcpA has also
been reported to be implicated in the regulation of genes
encoding for cell surface proteins important for coloniza-
tion (23).
Involvement of glucose and CcpA in sporulation
It has been recently described that CcpA is one of the few
regulators present in the proteome of C. difficile spores
(63). Sporulation and germination are key events of the
infectious cycle of C. difficile (31), and spores mainly con-
tribute to nosocomial transmission. In C. difficile, the
global response regulator Spo0A (CD1214) and the
associated sensor histidine kinase CD1579 (64) are
involved in the sporulation initiation. We observed from
the transcriptome that CcpA negatively regulated spo0A
and CD1579 expression in the presence of glucose
(Supplementary Table S2). By qRT-PCR, we further
demonstrated that spo0A was also 2–3-fold repressed by
glucose (Supplementary Table S4). Moreover, the
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expression of several genes involved in different stages of
sporulation, such as sigE (CD2643) and sigG (CD2642)
and spoIIAA-spoIIAB-sigF (CD0770–CD0772), spoIIE
(CD3490), spoIIIAG (CD1198), spoIVA (CD2629) and
spoVS (CD1935), was repressed by glucose in the
absence of CcpA. CcpA also negatively regulated most
of these spo genes in the absence of glucose (Supple-
mentary Table S2). Furthermore, we found that the
spo0A gene encoding the key regulator of the initiation
of sporulation and the spoIIAA-spoIIAB-sigF operon,
which is responsible for the synthesis and the activation/
inactivation of SigF (involved in the endospore forma-
tion), are direct targets that contain creCD sites (Table 2)
to which CcpA is able to bind (Figures 2 and 4B).
We further tested the involvement of glucose and CcpA
inactivation on the sporulation efficiency during 96 h of
growth (Figure 8). After 48 h of growth, we observed that
the sporulation efficiency of JIR8094 and ccpA mutant
strains was similar and strongly reduced when glucose
was added. This indicates that sporulation is strongly re-
pressed by glucose and that this repression does not
involve CcpA. This has already been reported for
C. perfringens where glucose-mediated catabolite repres-
sion of sporulation is not because of CcpA activity (26).
Therefore, like in C. perfringens, glucose-repression of C.
difficile sporulation implicates a still uncharacterized
CcpA-independent pathway. In addition, CcpA is
required for sporulation in C. perfringens in the absence
of glucose, with a 60-fold drop in sporulation efficiency in
a ccpA mutant at 24 h of growth in DSSM medium (26).
On the contrary, in C. difficile, the rate of sporulation
efficiency in the absence of glucose was 8–37-fold higher
in the ccpA mutant compared with the JIR8094 strain at
24 h of growth in SM medium (Figure 8A). This is in
agreement with the transcriptome results showing that
CcpA is implicated in the repression of genes involved
in the control of the first stages of sporulation like the
SpoIIAA operon and the SpoIIE phosphatase
(Supplementary Table S2).
Complex regulatory network mediated by CcpA
There are few studies concerning the combination of regu-
lators that control gene expression during host infection.
The data generated herein demonstrated that glucose and/
or CcpA controlled the expression of 67 regulators
(Supplementary Table S2). Twenty of them were regulated
by glucose through a CcpA-dependent mechanism. We
deduced from the transcriptome analysis that CcpA
controlled 30 regulators, and we revealed by ChIP-on-
Chip experiments that five transcriptional regulators
(rbsR, cggR, CD1584, CD2111 and spo0A) and a sensor
histidine–kinase (virS) were direct CcpA targets (Table 2).
However, regulation of expression of genes encoding the
DeoR type regulator CD2111 and VirS was not observed
in the transcriptome conditions used, and this may be
because of the low level of their expression. In addition,
the CcpA-controlled regulatory genes CD1428 and
CD3031 contain a creCD site (Supplementary Table S2).
We suggest that these seven CcpA direct targets may
mediate through a cascade of regulation part of the
indirect regulation by CcpA observed in our analysis.
Finally, CcpA indirectly controlled several additional
regulators (Supplementary Table S2). These regulators
might be under the control of direct CcpA regulators or
their activity might be modulated by other mechanisms,
including changes in the availability of metabolic effectors
as proposed for CggR and CcpC in B. subtilis (65).
Interestingly, in B. subtilis, a cre sequence is located
upstream of cggR, but cggR transcription is affected by
a ccpA deletion independently of this cre (65,66).
The ability of CcpA to promote different regulatory
outcomes, leading to activation or repression, suggests
that additional modulating signals and/or regulatory
pathways might interact with CcpA in the regulation of
specific target genes. CodY is a pleiotropic transcriptional
regulator that monitors the nutrient sufficiency of the en-
vironment. In C. difficile, CodY regulates the toxin genes,
and genes implicated in amino acids biosynthesis, nutrient
transport, fermentation and sporulation (67). Several
genes are found directly regulated by CcpA and CodY.
It is the case of toxin specific regulator gene tcdR, the
oppBCADF operon for oligopeptide transport, the
butyrate metabolism operon (CD1054–CD1059) or genes
implicated in the early stages of sporulation, such as the
spoIIAA operon and spoIIE (67). This means that CcpA
and CodY play a major role in several circuits of
Figure 8. Effect of glucose addition or CcpA inactivation on the sporulation efficiency. Comparison of sporulation efficiency of C. difficile JIR8094
and ccpA mutant strains grown in SM medium supplemented or not supplemented with 0.5% of glucose at 24 h (A), 48 h (B) and 96 h (C). Total cell
counts were obtained by enumeration of CFUs derived from serial dilutions of the initial culture plated on BHI agar supplemented with 0.1% of
taurocholate. The same procedure was applied for spore counts with an additional step of heat treatment at 60"C for 30min, to select for heat
resistant spores. Percentage of sporulation is the ratio between the spore titer and total cell titer at each time point. The mean and standard error of
three experiments are shown.
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regulation in C. difficile and that these circuits could
overlap between them rendering even more complex the
regulatory network.
CONCLUSION
In conclusion, our results show the importance of the
global regulator CcpA in C. difficile as a key factor
controlling several processes, such as selective utilization
of carbon sources, differential fermentation pathways,
amino acid metabolism and toxin production in
response to glucose availability. The identification of
CcpA targets in vivo and in vitro, and also the definition
of the C. difficile cre consensus allow us to dissociate direct
and indirect effects of CcpA. The CcpA direct targets are
mainly involved in the utilization of alternative sugar
sources (PTS or non-PTS sugar transporters), in fermen-
tation pathways leading to the production of butyrate, in
Stickland reactions, in toxin synthesis and in regulatory
functions including two key steps of the initiation of
sporulation.
Phylogeny analysis shows that CcpA of C. difficile
clusters with that of clostridia, but not with CcpA of
bacilli (30). Interestingly, we found putative creCD-like
sites in the regulatory regions of genes known to be
controlled by CcpA in other clostridia, including the
xylose utilization gene xylB in C. acetobutylicum (22)
and the perfringolysin O gene pfoA in C. perfringens
(29). A comparative genomic analysis of distribution of
CcpA binding sites in bacteria from the bacilli and
clostridia groups reinforces these observations on the di-
vergence of the cre motifs in these two phylogenetically
distant groups of Firmicutes and the relatively good con-
servation of the cre motifs inside of the clostridia and
bacilli groups (D.A.R and N.V.S, unpublished observa-
tion). The characterization of a cre consensus motif for
clostridia will probably help for the determination of the
CcpA regulons, which remain poorly characterized in
clostridia compared with other Firmicutes.
The high number of regulators controlled by CcpA
either directly or indirectly suggests that CcpA plays a
central role in the hierarchical organization of the
genetic regulatory network of C. difficile as shown for B.
subtilis (68). We are also aware that C. difficile virulence
depends on coordinate interactions between multiple regu-
latory circuits. As an example, CodY has been shown to
have a direct role in the regulation of sporulation and of
toxin genes (67). The next step will be to understand how
CcpA and CodY, two major global regulators of metab-
olism, interact to coordinate virulence in response to en-
vironmental signals. In S. aureus, the trichloroacetic acid
cycle seems to be intimately integrated into regulating
virulence factor synthesis and biofilm formation through
specific or global regulators like CodY and CcpA (69). In
C. difficile, we might propose that the fermentation
processes are similarly correlated with the signal transduc-
tion pathways controlling virulence. Indeed, addition of
butyric acid induces toxin synthesis, and during high-
toxin synthesis, genes coding for the enzymes involved in
the formation of butyrate from succinate or acetyl-CoA
are upregulated (53,57). CodY and CcpA are implicated in
the regulation of genes involved in these fermentation
pathways and in toxin production linking these two
processes. Finally, it is possible that CcpA might also con-
tribute to the ability of this pathogen to obtain key nutri-
ents in the host environment and to colonize the gut.
Experiments are now in progress to further characterize
the role of CcpA and its regulon during growth and
survival in the animal models of CDI.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1–4 and Supplementary Figures 1
and 2.
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